Kappa free light chain index in multiple sclerosis and other inflammatory CNS diseases: a pilot single-center study from Argentina - Scorecard - MDSpire

Kappa free light chain index in multiple sclerosis and other inflammatory CNS diseases: a pilot single-center study from Argentina

  • By

  • Analisa Manin

  • Fernanda Ingenito

  • Evangelina Valeria Cores

  • Diego Alarcón Guerrero

  • Silvia Graciela Ramos

  • Andrés M. Villa

  • May 29, 2026

  • 0 min

Share

Clinical Scorecard: Assessment of Kappa Free Light Chain Index in Multiple Sclerosis and Other Inflammatory Central Nervous System Disorders: A Preliminary Study from Argentina

At a Glance

CategoryDetail
Condition
Key Mechanisms
Target PopulationPatients aged 16 years and older with suspected inflammatory neurological disorders.
Care Setting

Key Highlights

  • additional_context

Guideline-Based Recommendations

Diagnosis

    Management

      Monitoring & Follow-up

        Risks

          Patient & Prescribing Data

          Clinical Best Practices

          • expansion

          Related Resources & Content

          Original Source(s)

          Kappa free light chain index in multiple sclerosis and other inflammatory CNS diseases: a pilot single-center study from Argentina

          • by Analisa Manin, Fernanda Ingenito, Evangelina Valeria Cores, Diego Alarcón Guerrero, Silvia Graciela Ramos, Andrés M. Villa

          • May 29, 2026

          Related Content

          The Loan Cap That Could Shrink the Doctor Pipeline

          New federal limits on medical school borrowing may quietly reshape who becomes a physician—and where they practice.

          Digging deeper into NINJ1: its multifaceted role in central nervous system diseases

          Long-Term Outcomes of Ublituximab Treatment in Multiple Sclerosis: Findings from the ULTIMATE I and II Open-Label Extension Trials